Association Between Statin Use and Mortality in Parkinson's disease (PD)

被引：0
|
作者：
Park, M.
Hong, I.
Baek, M.
机构：
来源：
MOVEMENT DISORDERS | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
881
引用
收藏
页码：S400 / S401
页数：2
相关论文
共 50 条
  • [11] Statin use and the risk of Parkinson's disease
    Wahner, A. D.
    Bronstein, J. M.
    Bordelon, Y. M.
    Ritz, B.
    MOVEMENT DISORDERS, 2007, 22 : S172 - S172
  • [12] Statin use and Parkinson’s disease incidence
    Tomoyuki Kawada
    Neurological Sciences, 2021, 42 : 2559 - 2559
  • [13] Association Between Genetic Polymorphisms and Disease Progression in Parkinson's disease (PD)
    Fang, T. C.
    Guo, Y. J.
    Chang, M. H.
    MOVEMENT DISORDERS, 2024, 39 : S762 - S763
  • [14] Exploring the Association between Statin Use and the Risk of Parkinson's Disease: A Meta-Analysis of Observational Studies
    Poly, Tahmina Nasrin
    Islam, Md. Mohaimenul
    Walther, Bruno Andreas
    Yang, Hsuan-Chia
    Phung-Anh Nguyen
    Huang, Chih-Wei
    Shabbir, Syed-Abdul
    Li, Yu-Chuan
    NEUROEPIDEMIOLOGY, 2017, 49 (3-4) : 142 - 151
  • [15] The association between lifestyle factors and Parkinson's disease progression and mortality
    Paul, Kimberly C.
    Chuang, Yu-Hsuan
    Shih, I-Fan
    Keener, Adrienne
    Bordelon, Yvette
    Bronstein, Jeff M.
    Ritz, Beate
    MOVEMENT DISORDERS, 2019, 34 (01) : 58 - 66
  • [16] The effect of statin use on cognition in Parkinson's disease
    Deck, B. L.
    Rick, J.
    Xie, S. X.
    Chen-Plotkin, A.
    Duda, J. E.
    Morley, J. F.
    Chahine, L. M.
    Dahodwala, N.
    Akhtar, R. S.
    Trojanowski, J. Q.
    Weintraub, D.
    MOVEMENT DISORDERS, 2016, 31 : S475 - S476
  • [17] Statin use and pneumonia risk in Parkinson's disease
    Yun, Seo Jung
    Byun, Seong Jun
    Kim, Han-Joon
    Oh, Byung-Mo
    Lee, Da Yun
    Park, Sang Jun
    Seo, Han Gil
    PARKINSONISM & RELATED DISORDERS, 2021, 91 : 124 - 127
  • [18] Association Between Use of Furosemide and Risk of Parkinson's Disease
    Babar, Barkat Ali
    Tolppanen, Anna-Maija
    Hartikainen, Sirpa
    Tiihonen, Miia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 379 - 379
  • [19] Association between olfactory dysfunction and neuropsychiatric manifestations in Parkinson's disease (PD)
    Kawashima, N.
    Hasegawa, K.
    Horiuchi, E.
    Yokoyama, T.
    Kumon, A.
    Matsunaga, A.
    Saito, M.
    MOVEMENT DISORDERS, 2012, 27 : S510 - S510
  • [20] The Role of Pathology Validation on the Association Between Smoking and Parkinson's disease (PD)
    Pecoraro, P.
    Carbone, S.
    Alessi, F.
    Di Lazzaro, V.
    di Biase, L.
    MOVEMENT DISORDERS, 2024, 39 : S839 - S839
12345